Studies

E-MOTIVE

EAGLE

EAGLE-2

EAGLE-3

Early High Protein in Critical Illness

Early liver transplantation for severe alcoholic hepatitis

Early mobilization in the ICU

Early MRI for low back pain

Early palliative care for metastatic NSLC

EARLY TAVR

Early TIPS for variceal hemorrhage

EARLY-SIMPLIFIED

EARLY-UNLOAD

EARLYDRAIN

EARNEST

EASE

EAST-AFNET 4

EAT-ICU

ECASS III

ECHELON-1

ECHOGUIDE

EchoPAIN

ECLA PHRI COLCOVID

ECLS-SHOCK (1-year follow-up)

ECLS-SHOCK (original research)

ECOSPOR III

ECOSPOR III (post-hoc analysis)

ECST

EFFAMPART

EFFECT (electronic cigarettes vs. placebo)

EFFECT (electronic cigarettes vs. varenicline)

Effect of Screen Time on Recovery From Concussion

EFFECTS

EID LIFE

EINSTEIN-PE

EIRPI

ELAIN

ELAIN FOLLOW-UP

ELATIVE

ELDERCARE-AF (subanalysis)

ELEKT-D

ELEVATE

ELIXA

EMBARK

EMBARK (enzalutamide monotherapy)

EMBARK (enzalutamide plus leuprolide)

EMBOLISE

EMBRACE (ambulatory ECG monitoring)

EMBRACE (azithromycin)

EMERGE

EMERGENT-1

EMERGENT-3

EMILIA

EMMA

EMPA-HEART2 CardioLink-7

EMPA-KIDNEY

EMPA-KIDNEY (long-term follow-up)

EMPA-REG OUTCOME

EMPACT-MI

EMPACTA

EMPEROR-Preserved

EMPEROR-Reduced

EMPHASIS-HF

EMPULSE

ENGAGE AF-TIMI 48 (edoxaban 30 mg)

ENGAGE AF-TIMI 48 (edoxaban 60 mg)

ENGAGE AF-TIMI 48 (post-hoc analysis, edoxaban 60 mg vs. 30 mg)

ENGAGE AF-TIMI 48 (post-hoc analysis, edoxaban vs. warfarin)

ENGAGES-CANADA

ENHANCE-1

ENHANCE-2

ENRICH

ENTRUST-AF PCI

ENZAMET

EOLIA

EORTC-62092 STRASS

EPaNIC (2-year follow-up)

EPaNIC (original research)

EPCAT I

EPCAT II

EPHESUS

EPIC-CAD

EPIC-HR

EPICC

EPIPAN

EPO-TBI (6-month outcomes)

EPO-TBI (long-term follow-up)

EPVent2

ERADICATE

Erenumab for Medication Overuse Headache (140 mg)

Erenumab for Medication Overuse Headache (70 mg)

ERSPC

ESCAPe (community-acquired pneumonia)

ESCAPE (heart failure)

ESCAPE-TRD

ESCORT-NEO/NCCES01 (camrelizumab plus albumin-bound paclitaxel and cisplatin)

ESCORT-NEO/NCCES01 (camrelizumab plus paclitaxel and cisplatin)

ESPRIT

ESSENCE

ESTxENDS

ETESRTA

EUCLID

EUPHRATES

EuRIDICE

EUROPA

European Dexamethasone Study

EVER-132-002

EVEREST-Outcomes

EVNP

Evolut low risk

EVOLVE

EX-DHF

EXCEL

EXPEDITION3

EXPLORER-HCM

explorer7

EXSCEL

EXTEND

EXTEND-IA

EXTEND-IA TNK

EXTRA

EXTRA-CVD

EXTUB-OBESE